| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/17/2008 | CN101268051A Isotopically substituted proton pump inhibitors |
| 09/17/2008 | CN101268050A Isotopically substituted pantoprazole |
| 09/17/2008 | CN101268041A Sulphonamide derivatives |
| 09/17/2008 | CN101268039A Novel carboxylic acid derivatives |
| 09/17/2008 | CN101265230A No-catalyst hydrolysis method for preparing nicotinic acid from nicotinonitrile in near-critical water medium |
| 09/17/2008 | CN101265229A Method for preparing 2-substituted-6-trifluoromethylnicotinonitrile or acid thereof |
| 09/17/2008 | CN101265228A Method for preparing 2-chloro-3-trichloromethyl-6-trifluoromethylpyridine |
| 09/17/2008 | CN100418963C Novel herbicides |
| 09/17/2008 | CN100418952C Biphenyl derivatives and their use as fungicides |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418949C Process for producing pyridylethylthio compound, modified ion exchanger and process for producing the same, and process for producing bisphenol compound |
| 09/17/2008 | CN100418948C Hydroxypyridine cgrp receptor antagonists |
| 09/16/2008 | US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/16/2008 | US7425639 Process |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425570 Pyridoxine and pyridoxal analogues: new uses |
| 09/16/2008 | US7425568 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 09/16/2008 | US7425557 Inhibitors of glycogen synthase kinase 3 |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/12/2008 | WO2008109697A2 Ppar active compounds |
| 09/12/2008 | WO2008109007A1 Bridged phenanthridines |
| 09/12/2008 | WO2008108735A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease |
| 09/12/2008 | WO2008107480A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators |
| 09/12/2008 | WO2008107365A1 New compounds |
| 09/12/2008 | WO2008107335A1 Aminoamides as orexin antagonists |
| 09/12/2008 | WO2008107334A2 Process for the synthesis of glyt-1 inhibitors |
| 09/12/2008 | WO2008107211A2 Novel p2y12 receptor antagonists |
| 09/12/2008 | WO2008106860A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | WO2008082509A3 Process for the synthesis of diaminopyridines from glutaronitriles |
| 09/12/2008 | WO2008053044A3 Hetaryl carbon acid-n-(biphen-2-yl)amide compounds |
| 09/12/2008 | WO2007113309A3 Compounds which inhibit the glycine transporter and uses thereof |
| 09/12/2008 | WO2007107594A3 Six-membered heterocycle substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 09/12/2008 | CA2696232A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | CA2680125A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2-receptor modulators |
| 09/12/2008 | CA2679844A1 Ppar active compounds |
| 09/12/2008 | CA2679314A1 New compounds |
| 09/12/2008 | CA2679039A1 Aminoamides as orexin antagonists |
| 09/12/2008 | CA2678630A1 Synthesis of glyt-1 inhibitors |
| 09/11/2008 | US20080221177 for controlling phytopathogenic harmful fungi |
| 09/11/2008 | US20080221176 treatment of diabetes mellitus, cardiovascular disease, dyslipidemia, artherosclerosis, peripheral vascular disease, inflammation, cancer, and diseases of the central nervous system; 1,1,1,3,3,3-hexafluoro-2-{4-[methyl(phenylmethyl)amino]phenyl}-2-propanol |
| 09/11/2008 | US20080221175 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| 09/11/2008 | US20080221171 neoplastic disease, autoimmune disease, transplantation related pathology and/or degenerative disease; selectively inducing apoptosis in cancer cells |
| 09/11/2008 | US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents |
| 09/11/2008 | US20080221112 New utilities of amide compounds |
| 09/11/2008 | US20080221020 Dendrimers as Molecular Translocators |
| 09/11/2008 | US20080220286 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films |
| 09/11/2008 | US20080220265 First and second electrode; a first organic layer between the electrodes; the first organic layer is a non-electroluminescent, cross-linked metal complex; and a second organic layer is an emissive electroluminescent organic material |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/10/2008 | EP1967516A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases |
| 09/10/2008 | EP1967515A1 Heterocyclic compounds |
| 09/10/2008 | EP1967513A1 Novel P2Y12 receptor antagonists |
| 09/10/2008 | EP1966148A1 Carboxamides |
| 09/10/2008 | EP1966147A1 Carboxamides for controlling micro-organisms in plant and material protection |
| 09/10/2008 | EP1966144A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 09/10/2008 | EP1966143A2 Substituted aniline derivatives useful as histamine h3 antagonists |
| 09/10/2008 | EP1966142A2 New phenanthridine derivatives as bradykinin antagonists |
| 09/10/2008 | EP1966141A1 Six-membered heterocycles useful as serine protease inhibitors |
| 09/10/2008 | EP1966129A2 Carbonates of fenicol antibiotics |
| 09/10/2008 | EP1965805A1 Urea derivatives useful as calcium receptor modulators |
| 09/10/2008 | EP1965644A1 Novel herbicides |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | CN101263151A Process for production of ortho-metallized complex of iridium with homoligand |
| 09/10/2008 | CN101263118A Fungicide pyridinyloxy substituted phenylamidine derivatives |
| 09/10/2008 | CN101263107A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 09/10/2008 | CN101260076A Method for preparing 2-chloro-5-methylpyridine |
| 09/10/2008 | CN100417641C Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 09/09/2008 | US7423181 Aminoalkoxy-functional chalcones |
| 09/09/2008 | US7423169 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/09/2008 | US7423159 Agent for preventing or treating neuropathy |
| 09/09/2008 | US7423147 Therapy of Histamine H3 receptor mediated diseases |
| 09/09/2008 | US7423101 Catalyst composition and use thereof |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/09/2008 | US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/04/2008 | WO2008106692A1 Pim kinase inhibitors and methods of their use |
| 09/04/2008 | WO2008106006A1 Process for the preparation of certain substituted sulfilimines |
| 09/04/2008 | WO2008105968A1 Novel seh inhibitors and their use |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008104994A2 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 09/04/2008 | WO2008085064A3 Hydroxypyridinone chelating agents, their metal complexes and their use as mri contrast agents |
| 09/04/2008 | WO2008054956A3 Kinase inhibitors |
| 09/04/2008 | WO2008032334A8 Eco-friendly process for recovery of pyridine and/or its derivatives |
| 09/04/2008 | US20080214828 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 09/04/2008 | US20080214825 Method For Producing Substituted Halopyridines |
| 09/04/2008 | US20080214818 (C1BNO)2Ir(pic) complex; electroluminescent devices; material optics, electrochemistry, thermal stability, luminescent efficiency |
| 09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214628 Administering a compound (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl-4-penten-2-amine; attention deficit disorder |
| 09/04/2008 | US20080214627 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214616 Pyridine Derivatives as Dipeptedyl Peptidase Inhibitors |
| 09/04/2008 | US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics |
| 09/04/2008 | US20080214532 Carboxanilides as Microbiocides |
| 09/04/2008 | US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |